Literature DB >> 19171827

Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease).

N Preisler1, G Andersen, F Thøgersen, C Crone, T D Jeppesen, F Wibrand, J Vissing.   

Abstract

OBJECTIVE: We examined the effect of aerobic exercise in patients with spinal and bulbar muscular atrophy (SBMA). SBMA is caused by a defect androgen receptor. This defect causes motor neuron death, but considering the important function of androgens in muscle, it is possible that muscle damage in SBMA also occurs independently of motor neuron damage.
METHODS: Eight patients with SBMA engaged in regular cycling exercise for 12 weeks. Maximum oxygen uptake (Vo(2max)), maximal work capacity (W(max)), muscle morphology, citrate synthase (CS) activity, body composition, EMG, static strength measurements, lung function, plasma proteins, and hormones were evaluated before and after training. Evaluation of improvements in activities of daily living (ADL) was conducted after training.
RESULTS: W(max) increased by 18%, and CS activity increased by 35%. There was no significant change in Vo(2max) or any of the other variables examined before and after training, and the patients with SBMA did not feel improvements in ADL.
CONCLUSIONS: Frequent, moderate-intensity aerobic conditioning is of little beneficial effect in patients with spinal and bulbar muscular atrophy (SBMA). High levels of plasma creatine kinase and muscle regeneration indicate a primary myopathic affection, which, in parallel with the motor neuron deficiency, may attenuate the response to exercise training in patients with SBMA.

Entities:  

Mesh:

Year:  2009        PMID: 19171827     DOI: 10.1212/01.wnl.0000341274.61236.02

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

Review 1.  Therapeutic approaches to spinal and bulbar muscular atrophy.

Authors:  Srikanth Ranganathan; Kenneth H Fischbeck
Journal:  Trends Pharmacol Sci       Date:  2010-09-20       Impact factor: 14.819

2.  Long-term exercise-specific neuroprotection in spinal muscular atrophy-like mice.

Authors:  Farah Chali; Céline Desseille; Léo Houdebine; Evelyne Benoit; Thaïs Rouquet; Bruno Bariohay; Philippe Lopes; Julien Branchu; Bruno Della Gaspera; Claude Pariset; Christophe Chanoine; Frédéric Charbonnier; Olivier Biondi
Journal:  J Physiol       Date:  2016-02-27       Impact factor: 5.182

3.  Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial.

Authors:  Christopher Grunseich; Ram Miller; Therese Swan; David J Glass; Mohamed El Mouelhi; Mara Fornaro; Olivier Petricoul; Igor Vostiar; Ronenn Roubenoff; Matthew N Meriggioli; Angela Kokkinis; Robert D Guber; Maher S Budron; John Vissing; Gianni Soraru; Tahseen Mozaffar; Albert Ludolph; John T Kissel; Kenneth H Fischbeck
Journal:  Lancet Neurol       Date:  2018-10-15       Impact factor: 44.182

Review 4.  Spinal and bulbar muscular atrophy: pathogenesis and clinical management.

Authors:  C Grunseich; C Rinaldi; K H Fischbeck
Journal:  Oral Dis       Date:  2013-05-09       Impact factor: 3.511

Review 5.  Spinal and Bulbar Muscular Atrophy.

Authors:  Christopher Grunseich; Kenneth H Fischbeck
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

6.  Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Satya L Reddy; Diane E Merry; Hiroaki Adachi; Masahisa Katsuno; Gen Sobue; Diane M Robins; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2013-10-22       Impact factor: 6.150

Review 7.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

Review 8.  Clinical Trials in Spinal and Bulbar Muscular Atrophy-Past, Present, and Future.

Authors:  Patrick Weydt; Anna Sagnelli; Angela Rosenbohm; Pietro Fratta; Pierre-François Pradat; Albert C Ludolph; Davide Pareyson
Journal:  J Mol Neurosci       Date:  2015-11-14       Impact factor: 3.444

Review 9.  Exercise Therapy in Spinobulbar Muscular Atrophy and Other Neuromuscular Disorders.

Authors:  Julia Rebecka Dahlqvist; John Vissing
Journal:  J Mol Neurosci       Date:  2015-11-19       Impact factor: 3.444

10.  Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy.

Authors:  Jacqueline Montes; Ashley M Goodwin; Michael P McDermott; David Uher; Feliz Marie Hernandez; Kayla Coutts; Julia Cocchi; Margarethe Hauschildt; Kayla M Cornett; Ashwini K Rao; Umrao R Monani; Carol Ewing Garber; Darryl C De Vivo
Journal:  Ann Clin Transl Neurol       Date:  2021-03-31       Impact factor: 5.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.